[Combined percutaneous ethanol injection through liver puncture and transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma].
OBJECTIVE
To study the therapeutic effects of transcatheter arterial chemoembolization (TACE) combined with beta-ultrasound guided percutaneous ethanol injection (PEI) at multiple points for hepatocellular carcinoma.


METHODS
Eighty-seven patients with hepatocellular carcinoma were divided into two groups: Group A, 45 patients were treated with TACE only, group B, 42 patients were treated with TACE plus PEI.


RESULTS
In group A patients, the 1-, 2-, and 3-year survival rates were 66.7%, 41.4%, and 21.4%, respectively. Only 26.1% of cancer specimens showed complete necrosis by pathologic examination in group A. In group B, the 1-, 2-, and 3-year survival rates were 97.1%, 85.71% and 65.71%, respectively, with complete necrosis in 81.8%.


CONCLUSIONS
The therapeutic effects of transcatheter arterial chemoembolization combined with percutaneous multiple point ethanol injection through liver puncture is much better than that of TACE alone.
Li
C
C
Department of Diagnostic Radiology, Cancer Institute (Hospital), Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China.
Shi
Z
Z
Hao
Y
Y
D000279:Administration, Cutaneous; D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D000431:Ethanol / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D015996:Survival Rate
D000431:Ethanol